Brand:
Dragon Pharma, Europe
Manufacturer:
Dragon Pharma, Europe
Dosage Info:
<div class="tab-pane fade" id="offer-tabbody--dosage-and-usage" role="tabpanel">
<section class="tab-panel" id="panel-usage">
<h2>Dosage & Usage Guidelines</h2>
<p>Establishing a precise Thymosin Alpha-1 dosage is critical for obtaining valid research data. As a potent research chemical, it is not intended for human consumption, and all studies must be designed with strict safety and ethical protocols. For the 10 mg vial from Dragon Pharma, researchers reconstitute the lyophilized powder with bacteriostatic water to achieve a precise concentration for subcutaneous administration.</p>
<p>Common research protocols are based on clinical studies and typically involve a dosage of 1.0 mg to 1.6 mg, administered two to three times per week. Some intensive protocols may initiate research with a "loading phase" of daily administration for 1-2 weeks before transitioning to the maintenance schedule of 2-3 times per week. The short half-life of approximately 2 hours is offset by its long-lasting effects on immune cell function, making frequent daily dosing unnecessary. Research should always commence at the lower end of the dosage spectrum to carefully monitor the subject's response.</p>
<h3>Thymosin Alpha-1 Cycle</h3>
<p>Designing an effective Thymosin Alpha-1 research cycle requires an understanding of its role as a modulator rather than an acute stimulant. Immune system optimization is a process, and cycles are therefore typically longer than those for other peptides. A standard research cycle can range from 4 to 8 weeks, with some protocols extending to 12 weeks for chronic conditions. Given its excellent safety profile in research models, longer cycles are feasible, often followed by a break of 4-6 weeks.</p>
<p>Thymosin Alpha-1 is highly synergistic when studied alongside other recovery and performance compounds. For comprehensive tissue repair and injury recovery, it is often stacked with <a href="https://www.dragonpharma.net/peptides-414/bpc-157-48731" title="Dragon Pharma BPC-157">BPC-157</a>. To accelerate muscle recovery and reduce systemic inflammation, researchers frequently combine it with <a href="https://www.dragonpharma.net/buy-2194/tb-500-41640" title="Dragon Pharma TB-500">TB-500</a>. During intense cutting phases where immune function can be compromised, adding a metabolic optimizer like <a href="https://www.dragonpharma.net/peptides-414/aicar-50-mg-87536" title="Dragon Pharma Aicar 50 mg">Aicar 50 mg</a> can provide valuable data. For those studying the effects of deep, restorative sleep on immunity and recovery, <a href="https://www.dragonpharma.net/peptides-414/dsip-10-mg-87537" title="Dragon Pharma DSIP 10 mg">DSIP 10 mg</a> is an excellent research companion. Finally, to support overall cellular health and combat oxidative stress during training, <a href="https://www.dragonpharma.net/peptides-414/ghk-cu-50-mg-86640" title="Dragon Pharma GHK-cu 50 mg">GHK-cu 50 mg</a> can be incorporated into the observational protocol.</p>
<h3>Possible Side Effects</h3>
<p>Thymosin Alpha-1 is renowned in research for its exceptional safety profile and high tolerance. Because it works by modulating the body's own systems rather than introducing a foreign mechanism, side effects are rare and typically very mild when observed. The most commonly reported issue in some research models is minor discomfort, redness, or itching at the injection site, which is common with many subcutaneous peptides.</p>
<p>In very rare instances, if a subject has an underlying and undiagnosed autoimmune condition, there is a theoretical risk of exacerbating the condition due to the immunomodulatory action. However, in standard research models, this is not a common observation. There are no known cases of hepatotoxicity, renal toxicity, or hormonal imbalances associated with Thymosin Alpha-1. It does not cause water retention, high blood pressure, or any androgenic side effects. Its excellent tolerability is a key reason for its widespread research interest. This compound is strictly for controlled laboratory research and is not meant for human consumption.</p>
<h3>Reconstitution and Research Protocol</h3>
<p>Proper handling of Dragon Pharma Thymosin Alpha-1 is essential to preserve its bioactivity and ensure research integrity. The lyophilized powder must be stored in a refrigerated environment between 2°C and 8°C (36°F and 46°F) at all times, both before and after reconstitution. To prepare the peptide for research, it must be reconstituted gently with bacteriostatic water. The water should be injected slowly down the side of the vial, and the vial should be rolled gently between the palms until the solution is clear. Aggressive shaking should be avoided to prevent damaging the peptide's structure.</p>
<p>Given the multi-dose nature of the protocol, maintaining sterility is paramount. Once reconstituted, the solution remains stable for approximately 3-4 weeks when refrigerated. Researchers should mark the vial with the date of reconstitution and adhere to a strict aseptic technique every time a dose is drawn. Using alcohol swabs to clean the rubber stopper before each insertion is a standard best practice to prevent microbial contamination.</p>
<h3>Research Applications and Synergies</h3>
<p>The primary research application for Thymosin Alpha-1 in athletic models revolves around preventing the "open window" of immunosuppression that follows prolonged, intense exercise. During this period, athletes are more susceptible to upper respiratory tract infections. Research focuses on how Ta1 can shorten or close this window, ensuring consistent training. Beyond general immunity, its hepatoprotective properties make it a subject of interest for studies involving compounds that can stress the liver, and its role in enhancing vaccine response is a key area of immunological research.</p>
<p>Its synergy with other peptides is profound. When stacked with BPC-157 and TB-500, it creates a powerful "recovery trifecta," addressing immune function, local tissue repair, and systemic healing simultaneously. For researchers studying cognitive performance under stress, its potential anti-anxiety effects and synergy with nootropics like <a href="https://www.dragonpharma.net/peptides-414/selank-45651">Selank</a> are also of significant interest.</p>
</section>
</div>
Technical Details
Peptide Type
N-Terminally Acetylated Polypeptide
Peptide Sequence
SDAAVDTSSEITTKDLKEKKEVVEEAEN
Peptide Length
28 Amino-Acid Residues
Terminal Form
Ac-SDAAVDTSSEITTKDLKEKKEVVEEAEN-OH
Molecular Formula
C₁₂₉H₂₁₅N₃₃O₅₅
Molecular Weight
3108.3 g/mol
Alternative Name
Thymalfasin
Biological Profile
Immune-Regulatory Signaling
